For the purposes of this document, the following terms and definitions apply in ukukhishwa kwe-ethylene oxide

3.1 Aeration

part of the eto gas sterilization process during which ethylene oxide and/or its

reaction products desorb from the medical device until predetermined levels are reached

Note 1 to entry: This can be performed within the sterilizer and/or in a separate chamber or room.

3.2 aeration area

either a chamber or a room in which aeration occurs

3.3 Bioburden

population of viable microorganisms on or in product and/or sterile barrier system

[SOURCE: ISO/TS 11139:2006, definition 2.2]

3.4 biological indicator

test system containing viable microorganisms providing a defined resistance to a specified eto gas sterilization process

3.5 Calibration

set of operations that establish, under specified conditions, the relationship between values of a quantity indicated by a measuring instrument or measuring

system, or values represented by a material measure or a reference material, and the corresponding values realized by standards

3.6 chemical indicator

test system that reveals a change in one or more pre-defined process variables

based on a chemical or physical change resulting from exposure to a process

[SOURCE: ISO/TS 11139:2006, definition 2.6]

3.7 Conditioning

treatment of product within the eto gas sterilizationtion cycle, but prior to ethylene

oxide admission, to attain a predetermined temperature and relative humidity

Note 1 to entry: This part of the ethylene oxide sterilization cycle can be carried out either at atmospheric pressure or under vacuum.

Note 2 to entry: See 3.27, preconditioning

3.8 D value

DOkuthenyalwayo value

time or dose required to achieve inactivation of 90 % of a population of the test microorganism under stated conditions

[SOURCE: ISO/TS 11139:2006, definition 2.11] ?

Note 1 to entry: For the purposes of this International Standard, the D value is the exposure time required to achieve 90 % inactivation of the population of the test organism.

3.9 Development

act of elaborating a specification

[SOURCE: ISO/TS 11139:2006, definition 2.13]

3.10 dew point

The temperature at which the saturation water vapour pressure is equal to the

partial pressure of the water vapour in the atmosphere

Note 1 to entry: Any cooling of the atmosphere below the dew point would produce water condensation.

3.11 Establish

determine by theoretical evaluation and confirm by experimentation

[SOURCE: ISO/TS 11139:2006, definition 2.17]

9ISO 11135-2014

3.12 ethylene oxide (EO) injection time 

duration of the stage beginning with the first introduction of the EO (mixture) into the chamber to the completion of that injection

3.13 exposure time

period for which the process parameters are maintained within their specified tolerances

[SOURCE: ISO/TS 11139:2006, definition 2.18]

Note 1 to entry: For the purpose of calculation of cycle lethality, it is the period of ethylene oxide sterilization between the end of EO injection and the beginning of EO removal.

3.14 Fault

one or more of the process parameters lying outside of its/their specified

tolerance(s)

[SOURCE: ISO/TS 11139:2006, definition 2.19]

3.15 Flushing

procedure by which the ethylene oxide is removed from the load and chamber

by either multiple alternate admissions of filtered air, inert gas or steam and evacuations of the chamber or continuous passage of filtered air, inert 10ISO 11135-2014 gas or steam through the load and chamber

3.16 fractional cycle

a cycle in which the exposure time to EO gas is reduced compared to that

specified in the ethylene oxide sterilization process

3.17 half cycle

a cycle in which the exposure time to EO gas is reduced by 50 % compared to that specified in the ethylene oxide sterilization process

3.18 health care facility

izinhlangano zikahulumeni nezizimele kanye nezikhungo ezizinikele ku

ukugqugquzelwa nokugcinwa kwezempilo, kanye nokuvinjelwa nokwelashwa

izifo nokulimala

ISIBONELO Isikhungo sokunakekelwa kwezempilo kungaba yisibhedlela, ikhaya labahlengikazi, indawo yokunakekela enwetshiwe, isikhungo sokuhlinza samahhala, umtholampilo, ihhovisi lezokwelapha, noma ihhovisi lamazinyo.

3.19 umkhiqizo wokunakekelwa kwezempilo

i(izi)setshenziswa zokwelapha, okuhlanganisa ku-vitro idivayisi(s) yezokwelapha ezixilongayo, noma imikhiqizo yokwelapha, kuhlanganisa ne(s) biopharmaceutical

11 ISO 11135-2014

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.20]

3.20 ukufakwa iziqu

inqubo yokuthola kanye nokubhala ubufakazi bokuthi okokusebenza kuhlinzekiwe

futhi ifakwe ngokuhambisana nokucaciswa kwayo

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.22]

3.21 idivayisi yezokwelapha

noma iyiphi insimbi, okokusebenza, okokusebenza, umshini, into esetshenziswayo, into efakwayo, ku-vitro i-reagent noma i-calibrator, isofthiwe, impahla noma i-athikili ehlobene, ehloselwe umenzi ukuthi isetshenziswe, yedwa noma inhlanganisela, kubantu ngenjongo eyodwa noma ngaphezulu

- ukuxilongwa, ukuvimbela, ukuqapha, ukwelashwa noma ukunciphisa izifo,

- ukuxilongwa, ukuqapha, ukwelashwa, ukunciphisa, noma isinxephezelo sokulimala,

- uphenyo, ukushintshwa noma ukuguqulwa noma ukusekelwa kwe-anatomy noma inqubo ye-physiological,

- ukulawula ukukhulelwa,

- ukukhishwa kwemishini yezokwelapha,

- ukuhlinzeka ngolwazi ngezinjongo zokwelapha ngokusebenzisa ku-vitro examination of specimens derived from the human body, and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means

[SOURCE: ISO 13485:2003, definition 3.7]

?

3.22 microorganism

entity of microscopic size, encompassing bacteria, fungi, protozoa and viruses

Note 1 to entry: A specific standard might not require demonstration of the

effectiveness of the eto gas sterilization process in inactivating all types of

microorganisms, identified in the definition above, for validation and/or

routine control of the eto gas sterilization process.

3.23 operational qualification

process of obtaining and documenting evidence that installed equipment

operates within predetermined limits when used in accordance with its

operational procedures

[SOURCE: ISO/TS 11139:2006, definition 2.27]

3.24 overkill approach

approach using eto gas sterilization process that delivers a minimum of 12 Spore Log

Reduction (SLR) to a biological indicator having a resistance equal to or greater than the product bioburden

3.25 parametric release

declaration that product is sterile, based on records demonstrating that the process parameters were delivered within specified tolerances

[SOURCE: ISO/TS 11139:2006, definition 2.29]

Note 1 to entry: This method of process release does not include the use of biological indicators.

3.26 performance qualification

inqubo yokuthola kanye nokubhala ubufakazi bokuthi okokusebenza, njengoba kufakiwe futhi kusetshenziswa ngokuhambisana nezinqubo zokusebenza, kusebenza ngokungaguquguquki ngokuya ngemibandela enqunywe kusengaphambili futhi ngaleyo ndlela kukhiqize umkhiqizo uhlangabezana nencazelo yawo.

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.30]

3.27 Imibandela yangaphambili

ukwelashwa komkhiqizo, ngaphambi komjikelezo wokuvala inzalo yegesi ye-eto, ekamelweni noma ekamelweni ukuze kutholwe izimo ezithile zokushisa nomswakama ohlobene

3.28 inqubo inselele idivayisi

into edizayinelwe ukuhlanganisa ukumelana okuchaziwe kunqubo yokuvala inzalo yegesi ye-aeto futhi isetshenziselwe ukuhlola ukusebenza kwenqubo.

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.33]

Qaphela 1 kokufakwayo: Ngenhloso yaleli Zinga lamazwe ngamazwe, i-PCD ingakwazi

kube umkhiqizo, umkhiqizo ofanisiwe noma esinye isisetshenziswa esigonyelwe ngqo noma

ngokungaqondile. Bheka u-7.1.6 kanye no-D.7.1.6.

Qaphela 2 kokufakwayo: Kuleli Zinga lamazwe ngamazwe, kwenziwa umehluko phakathi kwe-PCD yangaphakathi ne-PCD yangaphandle. I-PCD yangaphakathi isetshenziselwa ukukhombisa ukuthi umkhiqizo odingekayo we-SAL uyazuzwa. I-PCD etholakala ngaphakathi kwemikhawulo yomkhiqizo noma ikesi lomthumeli womkhiqizo i-PCD yangaphakathi, kuyilapho i-PCD etholakala phakathi kwamakesi omthumeli noma ngaphandle komthwalo i-PCD yangaphandle. I-PCD yangaphandle iyinto eklanyelwe ukusetshenziselwa i-microbiological

ukuqapha imijikelezo yokukhiqiza ejwayelekile.

3.29 ipharamitha yenqubo

inani elishiwo lokuguquguquka kwenqubo

Inothi 1 elizofakwa: Incazelo yenqubo yokuvala inzalo yegesi ye-eto ifaka phakathi

process parameters and their tolerances.

[SOURCE: ISO/TS 11139:2006, definition 2.34]

3.30 process variable

condition within a ethylene oxide sterilization process, changes in which alter microbicidal effectiveness

EXAMPLE?Time, temperature, pressure, concentration, humidity, wavelength.

[SOURCE: ISO/TS 11139:2006, definition 2.35]

3.31 processing category

collection of different product or product families that can be sterilized

together

Note 1 to entry: All products within the category have been determined to present an equal or lesser challenge to the ethylene oxide sterilization process than the process challenge device for that group.

3.32 Product

result of a process

[SOURCE: ISO 9000:2005, definition 3.4.2]

Note 1 to entry: For the purposes of ethylene oxide sterilization standards, product is

tangible and can be raw material(s), intermediate(s), sub-assembly(ies) and

health care products.

3.33 product family

group of product possessing characteristics that allow them to be sterilized

using defined process conditions

3.34 product load volume

defined space within the usable chamber volume occupied by product

3.35 recognized culture collection

depository authority under the Budapest Treaty on The International

Recognition of the Deposit of

Microorganisms for the Purposes of Patent and Regulation

[SOURCE: ISO/TS 11139:2006, definition 2.38]

3.36 reference microorganism

microbial strain obtained from a recognized culture collection

3.37 Requalification

repetition of part of validation for the purpose of confirming the continued acceptability of a specified process

3.38 reusable medical device

medical device designated or intended by the manufacturer as suitable for

reprocessing and re-use

Note 1 to entry: This is not a medical device that is designated or intended

by the manufacturer for single use only.

3.39 Services

supplies from an external source, needed for the correct function of equipment

EXAMPLE Electricity, water, compressed air, drainage.

[SOURCE: ISO/TS 11139:2006, definition 2.41]

3.40 single-use medical device

medical device designated or intended by the manufacturer for one-time use only

3.41 Specify

stipulate in detail within an approved document

3.42 Spore-log-reduction log of initial spore population, N0, minus the log of the final population, Nu

[SOURCE: ISO 14161:2009, definition 3.19]

Note 1 to entry: Describing the reduction in the number of spores on a

biological indicator or inoculated item produced by exposure to specified

conditions.

For Direct Enumeration:

SLR = log N0 log ? Nu

where

N0 is the initial population;

Nu is the final population.

For Fraction Negative:

SLR = log N0 – log [ln (q/n)]

where

N0 is the initial population;

q is the number of replicate samples tested;

n is the number of samples negative for growth.

If there are no survivors, the true SLR cannot be calculated. The SLR can be

reported as “greater than” log N0 if one surviving organism is used.

3.43 Sterile

free from viable microorganisms

[SOURCE: ISO/TS 11139:2006, definition 2.43]

3.44 sterile barrier system

minimum package that prevents ingress of microorganisms and allows aseptic

presentation of the product at the point of use

[SOURCE: ISO/TS 11139:2006, definition 2.44]

3.45 Sterility

state of being free from viable microorganisms

Note 1 to entry: In practice, no such absolute statement regarding the absence of microorganisms can be proven.

Note 2 to entry: See 3.47, sterilization.

[SOURCE: ISO/TS 11139:2006, definition 2.45]

3.46 sterility assurance level

probability of a single viable microorganism occurring on an item after

sterilization

Note 1 to entry: The term SAL takes a quantitative value, generally 10-6 or 10-3. When applying this quantitative value to assurance of sterility, an SAL of 10-6 has a lower value but provides a greater assurance of sterility than an SAL of 10-3.

[SOURCE: ISO/TS 11139:2006, definition 2.46]

3.47 Sterilization

validated process used to render product free from viable microorganisms

Note 1 to entry: In a sterilization process, the nature of microbial

inactivation is exponential and thus the survival of a microorganism on an individual item can be expressed in terms of probability. While this

probability can be reduced to a very low number, it can never be reduced to zero. ISO 11135-2014

Note 2 to entry: See 3.46, sterility assurance level.

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.47]

3.48 umjikelezo wokuvala inzalo

Ukwelashwa egumbini elivaliwe, okuhlanganisa ukukhishwa komoya, ukupholisa (uma kusetshenziswa), umjovo we-ethylene oxide, igesi engasebenzi (uma isetshenziswa), ukuchayeka ku-ethylene oxide, ukususwa kwe-ethylene oxide nokushaywa (uma kusetshenziswa), kanye nokungeniswa kwegesi yomoya/inert

3.49 umthwalo wokuvala inzalo

umkhiqizo ozoba, noma oseke wafakwa inzalo ndawonye kusetshenziswa into ethile

inqubo yokuvala inzalo

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.48]

3.50 inqubo yokuvala inzalo

uchungechunge lwezenzo noma imisebenzi edingekayo ukuze kuzuzwe izimfuneko ezishiwo zokuvala inzalo

[UMTHOMBO: ISO/TS 11139:2006, incazelo 2.49]

Inothi 1 okumele lifakwe: Lolu chungechunge lwezenzo noma imisebenzi luhlanganisa ukubeka kuqala imibandela

(if necessary), exposure to the ethylene oxide under defined conditions and any necessary post-treatment required for the removal of ethylene oxide and its by-products. It does not include any cleaning, disinfection or packaging operations that precede the sterilization process.

3.51 sterilization specialist

person with technical knowledge of the sterilization technology being utilized and its effects upon materials and microorganisms

3.52 sterilizing agent

ination of entities having sufficient microbicidal activity to achieve sterility under defined conditions

[SOURCE: ISO/TS 11139:2006, definition 2.50]

3.53 survivor curve

graphical representation of the inactivation of a population of microorganisms with increasing exposure to a microbicidal agent under stated conditions

[SOURCE: ISO/TS 11139:2006, definition 2.51]

3.54 test for sterility

technical operation defined in a Pharmacopoeia performed on product following exposure to a sterilization process

[SOURCE: ISO/TS 11139:2006, definition 2.53]

3.55 test of sterility

technical operation performed as part of development, validation, or

requalification to determine the presence or absence of viable microorganisms on product or portions thereof

[SOURCE: ISO/TS 11139:2006, definition 2.54]

3.56 usable chamber volume

defined space within the sterilizer chamber, which is not restricted by fixed or mobile parts and which is available to accept the sterilization load

Note 1 to entry: The volume allowed for gas circulation around the load inside

the chamber is not included as usable space.

3.57 Validation

documented procedure for obtaining, recording and interpreting the results required to establish that a process will consistently yield product complying with predetermined specifications

[SOURCE: ISO/TS 11139:2006, definition 2.55]

3.58 virgin material

material that has not been previously used, or subjected to processing other than for its original production

UMA UFUNA UKWAZI OKWENGEZIWE Nge-Ethylene Oxide Sterilization

Ucingo:+8619975258603

I-imeyili:hayley@hzbocon.com

Indawo Yendawo: Igumbi 1202, Caitong Zhongxin, Xiasha District, Hangzhou City, Zhejiang Province, China

Iwebhusayithi:hzbocon.com zjbocon.com

Skrolela phezulu